Search our Database of Scientific Publications and Authors

I’m looking for a
    The feasibility of an efficient drug design method with high-performance computers.
    Chem Pharm Bull (Tokyo) 2015 ;63(3):147-55
    Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo.
    In this study, we propose a supercomputer-assisted drug design approach involving all-atom molecular dynamics (MD)-based binding free energy prediction after the traditional design/selection step. Because this prediction is more accurate than the empirical binding affinity scoring of the traditional approach, the compounds selected by the MD-based prediction should be better drug candidates. In this study, we discuss the applicability of the new approach using two examples. Although the MD-based binding free energy prediction has a huge computational cost, it is feasible with the latest 10 petaflop-scale computer. The supercomputer-assisted drug design approach also involves two important feedback procedures: The first feedback is generated from the MD-based binding free energy prediction step to the drug design step. While the experimental feedback usually provides binding affinities of tens of compounds at one time, the supercomputer allows us to simultaneously obtain the binding free energies of hundreds of compounds. Because the number of calculated binding free energies is sufficiently large, the compounds can be classified into different categories whose properties will aid in the design of the next generation of drug candidates. The second feedback, which occurs from the experiments to the MD simulations, is important to validate the simulation parameters. To demonstrate this, we compare the binding free energies calculated with various force fields to the experimental ones. The results indicate that the prediction will not be very successful, if we use an inaccurate force field. By improving/validating such simulation parameters, the next prediction can be made more accurate.

    Similar Publications

    Molecular dynamics simulation-based evaluation of the binding free energies of computationally designed drug candidates: importance of the dynamical effects.
    Chem Pharm Bull (Tokyo) 2014 ;62(7):661-7
    Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo.
    The computational structure-based drug design (SBDD) mainly aims at generating or discovering new chemical compounds with sufficiently large binding free energy. In any de novo drug design methods and virtual screening methods, drug candidates are selected by approximately evaluating the binding free energy (or the binding affinity). This approximate binding free energy, usually called "empirical score," is critical to the success of the SBDD. Read More
    Physics-based methods for studying protein-ligand interactions.
    Curr Opin Drug Discov Devel 2007 May;10(3):325-31
    Department of Pharmaceutical Chemistry, University of California San Francisco, 600 16th Street, San Francisco, CA 94158-2517, USA.
    The accurate prediction of relative or absolute ligand-binding affinities is challenging in both theoretical and practical aspects. However, with the aid of advanced computing power and sophisticated methodology development, physics-based free-energy calculations, which can be used to predict ligand-binding affinities, have become increasingly utilized in the field of structure-based drug design. This review summarizes recent progress made in developing and applying physics-based methods to studying protein-ligand interactions, focusing on methods using molecular mechanics force fields. Read More
    Molecular modeling of hydration in drug design.
    Curr Opin Drug Discov Devel 2007 May;10(3):275-80
    Western Australian Biomedical Research Institute, School of Pharmacy, Curtin University of Technology, GPO Box U1987, Perth, WA 6845, Australia.
    The accurate prediction of the binding mode and affinity of a drug molecule to its putative receptor is crucial for successful drug design and optimization. Modeling the role of the aqueous solvent in ligand-protein interactions is one of the key components. Three main computational techniques have been developed to model hydration: free energy methods, ligand-protein docking and scoring, and the explicit inclusion of tightly bound water molecules in modeling. Read More
    The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Drug Discov Today 2015 Jun 20;20(6):686-702. Epub 2015 Jan 20.
    Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany. Electronic address:
    Among all tools available to design new drugs, molecular dynamics (MD) simulations have become an essential technique. Initially developed to investigate molecular models with a limited number of atoms, computers now enable investigations of large macromolecular systems with a simulation time reaching the microsecond range. The reviewed articles cover four years of research to give an overview on the actual impact of MD on the current medicinal chemistry landscape with a particular emphasis on studies of ligand-protein interactions. Read More